ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AOBI American Oriental Bioengineering Inc (CE)

0.0005
0.00 (0.00%)
20 Mar 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
American Oriental Bioengineering Inc (CE) USOTC:AOBI OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0005 0.00 00:00:00

Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against American Oriental Bioeng...

26/07/2012 12:54am

Business Wire


American Oriental Bioeng... (CE) (USOTC:AOBI)
Historical Stock Chart


From Mar 2020 to Mar 2025

Click Here for more American Oriental Bioeng... (CE) Charts.

Law Offices of Howard G. Smith announces that all purchasers of the securities of American Oriental Bioengineering, Inc. (“AOBI” or the “Company”) (OTC:AOBI) between November 9, 2009 and June 15, 2012, inclusive (the “Class Period”), have until August 22, 2012 to move the Court to serve as Lead Plaintiff in the securities fraud class action lawsuit filed in the United States District Court for the Central District of California.

AOBI engages in the development, manufacture and commercialization of pharmaceutical and healthcare products. The Complaint alleges that the defendants made false and misleading statements and/or failed to disclose material adverse facts about AOBI’s operations and financial performance. Specifically, defendants misrepresented and/or failed to disclose that: (1) certain of the Company’s capsule products maintained chrome levels far exceeding humanly tolerable limits; (2) the Company’s financial statements contained material inconsistencies; (3) the Company’s internal controls over financial reporting were deficient; and (4), as a result of the foregoing, the Company’s statements were materially false and misleading at all relevant times.

No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. If you purchased AOBI securities between November 9, 2009 and June 15, 2012, you have certain rights, and have until August 22, 2012 to move for lead plaintiff status. To be a member of the class you need not take any action at this time, or may retain counsel of your choice. If you wish to discuss this action or have questions concerning this Notice or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at 215-638-4847, Toll-Free at 888-638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

1 Year American Oriental Bioeng... (CE) Chart

1 Year American Oriental Bioeng... (CE) Chart

1 Month American Oriental Bioeng... (CE) Chart

1 Month American Oriental Bioeng... (CE) Chart

Your Recent History

Delayed Upgrade Clock